Company: RGNX
Filing Date: 2025-04-08
Form Type: DEF 14A
Source: 0000950170-25-052069
Chunk: 69

Company: REGENXBIO Inc.
Filing Date: 2025-04-08
Form: DEF 14A
Chunk 69
---
 2025, which is the expiration date of the 2015 Plan. Shareholder approval of the 2025 Plan and expiration of the 2015 Plan will not affect awards then outstanding under the 2015 Plan. The Board believes the adoption of the 2025 Plan is in the best interests of the Company and its stockholders, and recommends a vote “FOR” the approval of the 2025 Plan.

Why You Should Vote to Approve the 2025 Plan

The 2025 Plan Is Structured Favorably for Stockholders

The key features of the 2025 Plan—which incorporates numerous best practices in the stewardship of equity compensation—are as follows:

We removed the annual evergreen provisions providing for annual automatic share pool increases and there will be no more evergreen increases prior to the expiration of the 2015 Plan. An initial total of 5,500,000 shares will be reserved under the 2025 Plan. This number will be increased by shares that are subject to awards that were granted under the 2015 Plan, are still outstanding on the effective date of the 2025 Plan, and are later forfeited, expire, terminate, or are canceled without the delivery of all shares subject to the award (subject to certain equitable substitutions or adjustments determined by the Administrator for certain changes in capitalization set forth under the 2025 Plan). Similar recycling will also apply to awards granted under the 2025 Plan. The initial share pool represents approximately 11.0% of the shares of common stock outstanding as of the Record Date.

Awards granted under the 2025 Plan are subject to a minimum vesting provision that prohibits the vesting of any Award before one year from the date of grant, with the exception of 5% of the shares reserved for issuance under the 2025 Plan.

No options or stock appreciation rights (“SARs”) will be repriced or exchanged without stockholder approval, and no options or SARs with an exercise price equal to or exceeding the current fair market value of a share will be cancelled in exchange for a cash payment, subject to certain equitable substitutions or adjustments determined by the Administrator for certain changes in capitalization set forth under the 2025 Plan.

Liberal share recycling is prohibited under the 2025 Plan. The following shares will not again become available to be delivered pursuant to awards under the 2025 Plan: shares tendered or withheld to satisfy any tax obligation with respect to any grant, shares tendered or withheld to cover the exercise price